Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery: Effects of Linker Technology on Efficacy and Toxicity
Top Cited Papers
- 22 December 2005
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 17 (1), 114-124
- https://doi.org/10.1021/bc0502917
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Reduction−Alkylation Strategies for the Modification of Specific Monoclonal Antibody DisulfidesBioconjugate Chemistry, 2005
- Antibody-targeted chemotherapy of B-cell lymphoma using calicheamicin conjugated to murine or humanized antibody against CD22Cancer Immunology, Immunotherapy, 2004
- Tumor-Specific Novel Taxoid−Monoclonal Antibody ConjugatesJournal of Medicinal Chemistry, 2002
- Cathepsin B-Labile Dipeptide Linkers for Lysosomal Release of Doxorubicin from Internalizing Immunoconjugates: Model Studies of Enzymatic Drug Release and Antigen-Specific In Vitro Anticancer ActivityBioconjugate Chemistry, 2002
- Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugsPharmacology & Therapeutics, 1999
- Amplification and expression of mdr1 gene in a multidrug resistant variant of small cell lung cancer cell line NCI-H69British Journal of Cancer, 1989